| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 8 |
| NetGPI | no | yes: 0, no: 8 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 6 |
| GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: E9AW18
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 15 | 19 | PF00656 | 0.614 |
| CLV_NRD_NRD_1 | 131 | 133 | PF00675 | 0.600 |
| CLV_NRD_NRD_1 | 187 | 189 | PF00675 | 0.371 |
| CLV_PCSK_KEX2_1 | 131 | 133 | PF00082 | 0.571 |
| CLV_PCSK_SKI1_1 | 153 | 157 | PF00082 | 0.560 |
| CLV_Separin_Metazoa | 41 | 45 | PF03568 | 0.571 |
| DOC_CYCLIN_yCln2_LP_2 | 195 | 201 | PF00134 | 0.555 |
| DOC_PP2B_LxvP_1 | 195 | 198 | PF13499 | 0.557 |
| DOC_WW_Pin1_4 | 10 | 15 | PF00397 | 0.698 |
| LIG_14-3-3_CanoR_1 | 104 | 110 | PF00244 | 0.460 |
| LIG_14-3-3_CanoR_1 | 144 | 149 | PF00244 | 0.371 |
| LIG_14-3-3_CanoR_1 | 150 | 156 | PF00244 | 0.398 |
| LIG_Actin_WH2_2 | 173 | 190 | PF00022 | 0.319 |
| LIG_FHA_1 | 182 | 188 | PF00498 | 0.618 |
| LIG_FHA_1 | 66 | 72 | PF00498 | 0.419 |
| LIG_FHA_2 | 90 | 96 | PF00498 | 0.443 |
| LIG_LIR_Nem_3 | 193 | 197 | PF02991 | 0.608 |
| LIG_LIR_Nem_3 | 58 | 63 | PF02991 | 0.281 |
| LIG_SH2_SRC | 63 | 66 | PF00017 | 0.466 |
| LIG_SH2_STAT5 | 167 | 170 | PF00017 | 0.367 |
| LIG_SH2_STAT5 | 63 | 66 | PF00017 | 0.379 |
| LIG_SUMO_SIM_par_1 | 210 | 217 | PF11976 | 0.554 |
| LIG_TRAF2_1 | 73 | 76 | PF00917 | 0.314 |
| MOD_CK1_1 | 105 | 111 | PF00069 | 0.394 |
| MOD_CK1_1 | 154 | 160 | PF00069 | 0.436 |
| MOD_CK2_1 | 197 | 203 | PF00069 | 0.726 |
| MOD_CK2_1 | 35 | 41 | PF00069 | 0.619 |
| MOD_GlcNHglycan | 159 | 162 | PF01048 | 0.655 |
| MOD_GlcNHglycan | 209 | 212 | PF01048 | 0.486 |
| MOD_GlcNHglycan | 57 | 60 | PF01048 | 0.366 |
| MOD_GSK3_1 | 151 | 158 | PF00069 | 0.420 |
| MOD_GSK3_1 | 3 | 10 | PF00069 | 0.694 |
| MOD_N-GLC_1 | 102 | 107 | PF02516 | 0.609 |
| MOD_N-GLC_1 | 144 | 149 | PF02516 | 0.596 |
| MOD_NEK2_1 | 134 | 139 | PF00069 | 0.367 |
| MOD_NEK2_1 | 155 | 160 | PF00069 | 0.379 |
| MOD_NEK2_1 | 34 | 39 | PF00069 | 0.617 |
| MOD_NEK2_1 | 89 | 94 | PF00069 | 0.414 |
| MOD_NMyristoyl | 1 | 7 | PF02799 | 0.647 |
| MOD_PIKK_1 | 35 | 41 | PF00454 | 0.577 |
| MOD_PK_1 | 144 | 150 | PF00069 | 0.413 |
| MOD_PKA_2 | 66 | 72 | PF00069 | 0.405 |
| MOD_PKA_2 | 90 | 96 | PF00069 | 0.300 |
| MOD_PKB_1 | 142 | 150 | PF00069 | 0.360 |
| MOD_Plk_1 | 102 | 108 | PF00069 | 0.408 |
| MOD_Plk_1 | 144 | 150 | PF00069 | 0.408 |
| MOD_ProDKin_1 | 10 | 16 | PF00069 | 0.691 |
| TRG_DiLeu_BaEn_1 | 102 | 107 | PF01217 | 0.409 |
| TRG_DiLeu_BaEn_4 | 75 | 81 | PF01217 | 0.276 |
| TRG_ENDOCYTIC_2 | 167 | 170 | PF00928 | 0.385 |
| TRG_ER_diArg_1 | 141 | 144 | PF00400 | 0.462 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1IJU2 | Leptomonas seymouri | 55% | 100% |
| A0A1X0NGY8 | Trypanosomatidae | 27% | 100% |
| A0A3S7WXJ0 | Leishmania donovani | 90% | 100% |
| A4HCN1 | Leishmania braziliensis | 78% | 100% |
| A4I055 | Leishmania infantum | 89% | 100% |
| Q4QBF8 | Leishmania major | 89% | 100% |
| V5B4L7 | Trypanosoma cruzi | 30% | 95% |